Better Therapeutics, Inc. Profile Avatar - Palmy Investing

Better Therapeutics, Inc.

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in deve…

Biotechnology
US, San Francisco [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Better Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of BTTX's Analysis
CIK: 1832415 CUSIP: 08773T104 ISIN: US08773T1043 LEI: - UEI: -
Secondary Listings
BTTX has no secondary listings inside our databases.